RPS Diagnostics Employee Directory

BiotechnologyFlorida, United States11-50 Employees

RPS Diagnostics, based in Sarasota, Florida, operates in biotechnology as a developer, manufacturer, and marketer of point-of-care tests for systemic infectious diseases and antibiotic stewardship. Its FebriDx test provides rapid, in-office testing using a fingerstick blood sample to detect an immune response and to differentiate bacterial from viral causes of fever in acute respiratory infection, with results in about 15 minutes. The test has a 97% negative predictive value, enabling clinicians to triage patients during the initial visit and help reduce unnecessary antibiotic use.

FebriDx is commercially available outside the United States in markets including Australia, Canada, Europe, the Gulf region, Saudi Arabia, Singapore, and the United Kingdom; it has not received FDA clearance for U.S. use. In May 2022, RPS Diagnostics announced a collaboration with Atomo Diagnostics Limited to develop additional tests for febrile acute respiratory infections, reflecting ongoing external partnerships in its product development.

Sign up for free to view info

Company overview Email format